Search Results - "Fulcher, C A"

Refine Results
  1. 1
  2. 2

    MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases by Caspi, Ron, Foerster, Hartmut, Fulcher, Carol A, Kaipa, Pallavi, Krummenacker, Markus, Latendresse, Mario, Paley, Suzanne, Rhee, Seung Y, Shearer, Alexander G, Tissier, Christophe, Walk, Thomas C, Zhang, Peifen, Karp, Peter D

    Published in Nucleic acids research (01-01-2008)
    “…MetaCyc (MetaCyc.org) is a universal database of metabolic pathways and enzymes from all domains of life. The pathways in MetaCyc are curated from the primary…”
    Get full text
    Journal Article
  3. 3

    A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor by Foster, P A, Fulcher, C A, Marti, T, Titani, K, Zimmerman, T S

    Published in The Journal of biological chemistry (25-06-1987)
    “…We have identified a Factor VIII (FVIII) binding domain residing within the amino-terminal 272 amino acid residues of the mature von Willebrand Factor (vWF)…”
    Get full text
    Journal Article
  4. 4

    FVIII Inhibitor IgG Subclass and FVIII Polypeptide Specificity Determined by Immunoblotting by Carol, A. Fulcher, Sytske, de Graaf Mahoney, Theodore, S. Zimmerman

    Published in Blood (01-05-1987)
    “…We used immunoblotting of purified factor VIII coagulant protein (FVIII) to localize FVIII inhibitor epitopes in 76 inhibitor plasmas to either the 92-kd FVIII…”
    Get full text
    Journal Article
  5. 5

    Epitope Mapping of Human Factor VIII Inhibitor Antibodies by Deletion Analysis of Factor VIII Fragments Expressed in Escherichia coli by Scandella, Dorothea, Mahoney, Sytske DeGraaf, Mattingly, Mora, Roeder, David, Timmons, Lisa, Fulcher, Carol A.

    “…Epitopes for antibodies that inhibit factor VIII procoagulant protein were analyzed by deletion mapping of factor VIII protein fragments expressed in…”
    Get full text
    Journal Article
  6. 6

    Localization of Epitopes for Human Factor VIII Inhibitor Antibodies by Immunoblotting and Antibody Neutralization by Scandella, Dorothea, Mattingly, Mora, de Graaf, Sytske, Fulcher, Carol A.

    Published in Blood (01-10-1989)
    “…Human factor VIII(FVIII) inhibitors are pathologic, circulating antibodies that inactivate FVIII. We have examined the location of epitopes on the FVIII…”
    Get full text
    Journal Article
  7. 7

    Characterization of the Human Factor VIII Procoagulant Protein with a Heterologous Precipitating Antibody by Fulcher, Carol A., Zimmerman, Theodore S.

    “…The human factor VIII procoagulant protein (VIIIC) was purified from the VIIIC-factor VIII-related antigen (VIIIRAg) complex in commercial factor VIII…”
    Get full text
    Journal Article
  8. 8

    Proteolytic Inactivation of Human Factor VIII Procoagulant Protein by Activated Human Protein C and its Analogy With Factor V by Fulcher, Carol A., Gardiner, Joyce E., Griffin, John H., Zimmerman, Theodore S.

    Published in Blood (01-02-1984)
    “…Purified human factor VIII procoagulant protein (VIII:C) was treated with purified human activated protein C (APC) and the loss of VIILC activity correlated…”
    Get full text
    Journal Article
  9. 9

    Thrombin Proteolysis of Purified Factor VIII Procoagulant Protein: Correlation of Activation With Generation of a Specific Polypeptide by Fulcher, Carol A., Roberts, James R., Zimmerman, Theodore S.

    Published in Blood (01-04-1983)
    “…Factor VIII procoagulant protein (VIII:C) purified from commercial factor VIII concentrate contained multiple polypeptides ranging in mol wt from 79,000 to…”
    Get full text
    Journal Article
  10. 10

    Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide by Ware, J, MacDonald, M J, Lo, M, de Graaf, S, Fulcher, C A

    Published in Blood coagulation & fibrinolysis (01-12-1992)
    “…Previous epitope mapping studies of human factor VIII (FVIII) inhibitor antibodies with heavy chain specificity localized epitopes to the amino-terminal half…”
    Get more information
    Journal Article
  11. 11

    Human factor VIII procoagulant protein: monoclonal antibodies define precursor-product relationships and functional epitopes by FULCHER, C. A, ROBERTS, J. R, HOLLAND, L. Z, ZIMMERMAN, T. S

    Published in The Journal of clinical investigation (01-07-1985)
    “…The human Factor VIII procoagulant protein (VIII:C) purified from commercial Factor VIII concentrate consisted of a polypeptide doublet of 80,000 mol wt, a…”
    Get full text
    Journal Article
  12. 12

    An Arginine to Cysteine Amino Acid Substitution at a Critical Thrombin Cleavage Site in a Dysfunctional Factor VIII Molecule by Shima, Midori, Ware, Jerry, Yoshioka, Akira, Fukui, Hiromu, Fulcher, Carol A.

    Published in Blood (01-10-1989)
    “…We have analyzed the factor VIII (FVIII) protein and the nucleotide sequence around two thrombin cleavage sites, at arginine 372 in the FVIII heavy chain and…”
    Get full text
    Journal Article
  13. 13

    An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII molecule by Shima, M, Ware, J, Yoshioka, A, Fukui, H, Fulcher, CA

    Published in Blood (01-10-1989)
    “…We have analyzed the factor VIII (FVIII) protein and the nucleotide sequence around two thrombin cleavage sites, at arginine 372 in the FVIII heavy chain and…”
    Get full text
    Journal Article
  14. 14

    Immunoblot Analysis Shows Changes in Factor VIII Inhibitor Chain Specificity in Factor VIII Inhibitor Patients Over Time by Fulcher, Carol A., Lechner, Klaus, Mahoney, Sytske de G.

    Published in Blood (01-10-1988)
    “…We have used immunoblotting of purified factor VIII (FVIII) to determine whether or not changes in FVIII chain specificity occur during the course of an…”
    Get full text
    Journal Article
  15. 15

    Localization of the binding site for a factor VIII activity neutralizing antibody to amino acid residues Asp1663-Ser1669 by Shima, M, Fulcher, C A, de Graaf Mahoney, S, Houghten, R A, Zimmerman, T S

    Published in The Journal of biological chemistry (25-07-1988)
    “…We have identified the Factor VIII amino acid sequence Asp-Tyr-Asp-Asp-Thr-Ile-Ser (1663-1669) as the binding site of a Factor VIII activity neutralizing…”
    Get full text
    Journal Article
  16. 16

    Localization of Human Factor FVIII Inhibitor Epitopes to Two Polypeptide Fragments by Fulcher, Carol A., Sytske De Graaf Mahoney, Roberts, James R., Kasper, Carol K., Zimmerman, Theodore S.

    “…Epitopes for 22 alloantibodies that inhibit factor VIII procoagulant protein (FVIII) from multitransfused individuals with severe hemophilia A and three…”
    Get full text
    Journal Article
  17. 17

    An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor by Foster, P A, Fulcher, C A, Houghten, R A, Zimmerman, T S

    Published in The Journal of biological chemistry (15-04-1988)
    “…We have identified a monoclonal anti-factor VIII (FVIII) antibody, C4, which inhibits the binding of purified human FVIII to purified human von Willebrand…”
    Get full text
    Journal Article
  18. 18

    Synthetic Factor VIII Peptides With Amino Acid Sequences Contained Within the C2 Domain of Factor VIII Inhibit Factor VIII Binding to Phosphatidylserine by Foster, Paul A., Fulcher, Carol A., Houghten, Richard A., Zimmerman, Theodore S.

    Published in Blood (15-05-1990)
    “…The effective activation of factor × by factor IXa requires the co-factor activity of activated factor VIII (FVIII). Factor Xa formation is also dependent on…”
    Get full text
    Journal Article
  19. 19

    Enzyme-linked immunoassays for CRM positive hemophilia A using monoclonal antibodies with defined epitopes by Tanaka, I, Kasper, C K, Fulcher, C A

    Published in Thrombosis research (01-09-1992)
    “…Sensitive, monoclonal antibody-based, enzyme-linked immunosorbent assays (ELISAs) for plasma factor VIII (FVIII) antigen have been developed. The assays used…”
    Get more information
    Journal Article
  20. 20